Another interesting target in KMT2A-rearranged AML is the protein menin that interacts with KMT2A fusion proteins and seems to be an oncogenic cofactor in KMT2A driven leukemogenesis [103]. The gene discussed is MEN1; the disease is acute myeloid leukemia.